Roots Analysis
NOVEMBER 30, 2021
Bioassay – A Prerequisite for the Cell and Gene Therapy Development. Therefore, increase in development of cell and gene therapy domain has led to the rise in demand of bioassay services for cell and gene therapy. Bioassays are biochemical procedures that are used to evaluate the potency, purity and efficacy of a drug substance.
Pharmaceutical Technology
OCTOBER 12, 2022
As part of the collaboration, Toregem will use WuXi Biologics’ integrated CMC services in cell culture development, cell line development, bioassay development, biologics GMP manufacturing, cell banking and testing services, as well as other related services.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Discovery World
MARCH 4, 2024
DDW Editor Reece Armstrong speaks to Abraham Wang , Head of Marketing at Collaborative Drug Discovery (CDD) about annotated assays and the advantages they bring to research teams. All of these can delay research progress and jeopardise intellectual property claims.
Pharmaceutical Technology
FEBRUARY 15, 2023
Another area where we tend to see problems is in encapsulation efficiency,” says Andrew Kondratowicz, Bioassay Team Lead, Precision NanoSystems. The bioassays are the canary in the coal mine of how well your process development is going. Where is your payload? Where is it allocated?
Roots Analysis
JANUARY 16, 2023
At-home Self-testing Kit Manufacturers – Current Market Landscape. The market is highly fragmented, featuring the presence of both new entrants and established players, based in different geographical regions. At-home Self-testing Kits – Market Overview. At-home Self-testing Kits – Market Forecast and Opportunity Analysis.
Drug Discovery World
AUGUST 12, 2022
Some 5% of commercially available research compounds aresold as salt forms. By selecting the correct salt form for an assay or as a reagent, scientists can optimise their research projects, says Andrievs Auseklis Auzin, Developer, Molport, Latvia. The research chemical supply market.
Drug Discovery World
NOVEMBER 9, 2023
Novel platforms This session will begin with chariperson’s remarks from Lars Linden, PhD, Vice President, Head, Biologics Research, Bayer HealthCare, which will be followed by a keynote presentation by Agnieszka Kielczewska, PhD, Director, Research, Antibody Discovery and Screening, Biologics Discovery, Amgen.
Expert insights. Personalized for you.
52 
Let's personalize your content